心脏磁共振成像在主动脉瓣反流中的诊断与预后价值
该研究纳入232例慢性主动脉瓣反流患者,在超声心动图4周内行心脏磁共振检查,以舒张全期降主动脉逆向血流定义显著反流。磁共振对超声分级有显著重分类,且舒张全期逆向血流与N末端B型利钠肽原均为独立预后因素,提示磁共振可提供重要诊断与预后信息。
要点
- 超声轻度反流者6.8%在磁共振上出现舒张全期逆向血流。
- 超声重度反流者34.1%在磁共振上无舒张全期逆向血流,被重分类为非显著反流。
- 超声中度至重度反流者45.0%在磁共振上出现舒张全期逆向血流,提示重度反流。
核心结论
- 在慢性主动脉瓣反流中,心脏磁共振有潜力提供重要的诊断与预后信息。
- 仅N末端B型利钠肽原浓度(HR 2.184,95%CI 1.468–3.248,P<0.001)与磁共振舒张全期逆向血流(HR 2.774,95%CI 1.131–6.802,P=0.026)与结局独立相关。
研究设计与样本
- 研究类型为前瞻性随访研究,连续纳入232例慢性主动脉瓣反流患者(女性34.5%,年龄55.5±19.8岁),其中超声示中度至重度反流40例、重度反流44例。
- 所有患者在超声心动图4周内行心脏磁共振,包括相位对比速度编码成像测量窦管交界处反流体积与反流分数,并评估降主动脉舒张全期逆向血流。
- 以磁共振出现舒张全期逆向血流定义显著主动脉瓣反流,随访35.3±26.6个月,采用多因素Cox回归分析以心力衰竭、住院与心血管死亡组合为主要终点。
关键影像表现/征象
- 磁共振相位对比速度编码成像测量窦管交界处反流体积与反流分数,并评估降主动脉舒张全期逆向血流。
- 超声示轻度反流者中6.8%在磁共振上出现舒张全期逆向血流。
- 超声示重度反流者中34.1%在磁共振上无舒张全期逆向血流,被重分类为非显著反流。
- 超声示中度至重度反流(严重程度不确定)的40例中,45.0%在磁共振上出现舒张全期逆向血流,提示重度反流。
诊断标准与关键数值
- 显著主动脉瓣反流定义为心脏磁共振上出现舒张全期逆向血流。
- 随访35.3±26.6个月期间,63例(27.2%)达到组合终点,包括43例(18.5%)心力衰竭住院和20例(8.6%)心血管死亡。
- 多因素回归中N末端B型利钠肽原浓度HR 2.184(95%CI 1.468–3.248,P<0.001)。
- 多因素回归中磁共振舒张全期逆向血流HR 2.774(95%CI 1.131–6.802,P=0.026)。
临床应用与阅片要点
- 对超声反流严重程度分级不确定者,可参考磁共振舒张全期逆向血流评估显著反流。
- 磁共振可将部分超声重度反流重分类为非显著反流、将部分轻度反流识别为存在舒张全期逆向血流。
- 舒张全期逆向血流与N末端B型利钠肽原浓度可为慢性主动脉瓣反流提供预后信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study investigated the diagnostic and prognostic value of cardiac magnetic resonance (CMR) imaging in chronic aortic regurgitation (AR).
BACKGROUND: Accurate quantification of AR severity by echocardiography frequently remains difficult. CMR is recommended as the complementary method; however, its accuracy and prognostic utility remain unknown.
METHODS: A total of 232 consecutive patients (34.5% were females 55.5 ± 19.8 years of age) with chronic AR (including 40 with moderate to severe and 44 with severe AR on echocardiography) underwent CMR within 4 weeks of echocardiography. CMR included phase-contrast velocity-encoded imaging for the measurement of regurgitant volume and fraction at the sinotubular junction and assessment of holodiastolic retrograde flow (HRF) in the descending aorta. Significant AR was defined as the presence of HRF on CMR. Patients were followed prospectively, and multivariate Cox regression was applied for outcome analysis using a combination of heart failure, hospitalization, and cardiovascular death as primary endpoint.
RESULTS: AR severity on the basis of echo was reclassified in a significant number of patients according to CMR: 6.8% with mild AR on echo had HRF on CMR, whereas 34.1% with severe AR on echo did not have HRF on CMR and were reclassified as having nonsignificant AR. In 40 patients with uncertain AR severity (moderate to severe) on echo, 45.0% had HRF on CMR, indicating severe AR. Patients were followed for 35.3 ± 26.6 months. During that period, 63 patients (27.2%) reached the combined endpoint, including 43 (18.5%) with heart failure hospitalizations and 20 (8.6%) with cardiovascular deaths. By multivariate regression analysis, including clinical as well as imaging parameters, only N-terminal pro-B-type natriuretic peptide concentration (hazard ratio: 2.184 [95% confidence interval: 1.468 to 3.248]; p < 0.001) and HRF on CMR (hazard ratio: 2.774 [95% confidence interval: 1.131 to 6.802]; p = 0.026) remained significantly associated with outcome.
CONCLUSIONS: In chronic AR, CMR has the potential to add important diagnostic and prognostic information.
引用
- Kammerlander AA, Wiesinger M, Duca F, et al. Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation. JACC Cardiovasc Imaging. 2018. PMID: 30448117. doi:10.1016/j.jcmg.2018.08.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。